ppt bang ucup

Upload: vannyanoy

Post on 03-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Ppt Bang Ucup

    1/34

    Trial of Labor After Previous

    Cesarean DeliveryTOLAC

    The term trial of labor refers to a trial of labor in women who

    have

    had a previous cesarean delivery, regardless of the outcome.

    TOLAC MAY LEAD TO SUCCESFUL VBAC

  • 7/28/2019 Ppt Bang Ucup

    2/34

    ACOG # 115 2010

    Validate/Reference well performed studies & present

    a range of data (+/-) emphasizing that it may be

    reasonable to expand the CANDIDATE POOL.

    Extreme caution should STILL be exercised whenconsidering additional factors @ term which may

    influence the success or failure of VBAC

    THE MOST CLINICALLY USEFUL INFORMATION IN THE

    NEW BULLETIN

    TOLAC COUNSELING CALCULATOR

    MORTALITY /MORBIDITY % tge TABLES

  • 7/28/2019 Ppt Bang Ucup

    3/34

    The American College of Obstetricians and Gynecologists

    guidelines for identifying women who are potential candidates

    for TOLAC NOW include the following:

    WHO ARE NEW TOLAC CANDIDATES TWO previous low transverse uterine incisions Ok Twins Ok ECV Ok EGA > 40 weeks Ok One Low vertical Ok

    Suspected Macrosomia alone Ok

    Informed induction Ok however NO prostaglandins

    followed by oxytocin. ( Foley bulb followed by pitocin )

    Undocumented scar with out history suggesting classical c/s

    ACOG PRACTICE BULLETIN AUGUST Number 115, 2010

  • 7/28/2019 Ppt Bang Ucup

    4/34

    Contraindications for VBAC Prior classical or T-shaped uterine incision or extensive

    transfundal uterine surgery (eg, myomectomy)

    Previous uterine rupture (the frequency of repeat rupturevaries from 6 to 32 percent, respectively if the lower uterinesegment or the upper segment was the site of the initialrupture)

    No Cytotec

    Medical or obstetrical complications that preclude vaginal birth(eg, placenta previa)

    Inability to immediately perform emergency cesarean deliverydue to factors related to the facility, surgeon, anesthesia, ornursing staff

    Two or more prior uterine scars and no prior vaginaldeliveries. 2010 REMOVED two previous c/s andremained silent regarding previous vaginal delivery

    ACOG VBAC Bulletin # 54JULY 2004/ 2010 #115

  • 7/28/2019 Ppt Bang Ucup

    5/34

    Uterine Rupture

    By Incision Location

    The rate of rupture reported by incision

    location is:

    Classical (4 to 9 %)

    T-shaped (4 to 9 %)

    Low vertical (1 to 7 %)

    1 Low transverse ( 0.7 to 0.9 %)2 Low transverse ( 0.9-1.8 % )

  • 7/28/2019 Ppt Bang Ucup

    6/34

    2 previous C/S

    Candidates but Counsel Carefully

    Two large studies referenced by ACOG, with sufficient size to control for

    confounding variables, reported on the risks for women with two previous

    cesarean deliveries undergoing TOLAC.

    One study found no increased risk of uterine rupture (0.9% versus 0.7%) in

    women with one versus multiple prior cesarean deliveries , whereas the

    other noted a risk of Uterine Rupturethat increased from 0.9% to 1.8% (

    2X )in women with one versus two prior cesarean deliveries

    Both studies reported some increased risk in morbidity among women

    with more than one prior cesarean delivery although the absolute

    magnitude of the difference in these risks was relatively small (eg, 2.1%

    versus 3.2%) composite major morbidity in one study

  • 7/28/2019 Ppt Bang Ucup

    7/34

    2 PREVIOUS C/S

    ACOG 2010

    The chance ofachieving VBAC appears to be similarfor women with one or more than one cesareandelivery.

    Given the overall data, it is reasonable to consider

    women with two previous low transverse cesareandeliveries to be candidates for TOLAC

    Do Not forget to Counsel based on the

    combination of other factors that affect theprobability of achieving a successful VBAC.

  • 7/28/2019 Ppt Bang Ucup

    8/34

    Maternal Factors Associated

    VBAC SUCCESS Young maternal age

    Increased height

    Body mass index

  • 7/28/2019 Ppt Bang Ucup

    9/34

  • 7/28/2019 Ppt Bang Ucup

    10/34

    TOLAC/VBAC SUCCESS COUNSELING

    CALCULATOR 2010 ACOG A model was developed specifically for women

    undergoing TOLAC at term with one prior low

    transverse cesarean delivery incision, singletonpregnancy, and cephalic fetal presentation.

    This model may have utility for patient

    education and counseling for those consideringTOLAC at term

  • 7/28/2019 Ppt Bang Ucup

    11/34

    VAGINAL BIRTH AFTER CESAREAN

    Height & weight optional; enter them to automatically calculate BMI

    Maternal age

    Height (range 54-80 in.)

    Weight (range 80-310 lb.)

    Body mass index (BMI, range

    15-75)

    African-American?

    Hispanic?

    Any previous vaginal delivery?

    Any vaginal delivery sincelast cesarean?

    Indication for prior cesarean

    of arrest

    of dilation or descent?

  • 7/28/2019 Ppt Bang Ucup

    12/34

    SAMPLE PATIENT

    5 FOOT 3 INCHES

    225 LBS

    HISPANIC

    NO PREVIOUS VAGINAL DELIVERY

    PREVIOUS C/S FOR CPD

    Predicted chance of vaginal birth aftercesarean: 24.5% 95% CI: [21.3%, 28.1%]

  • 7/28/2019 Ppt Bang Ucup

    13/34

    CONSIDER THE RESULTS

    Consider additional Information

    It is designed for educational use and is based on a

    population of women who received care at the

    hospitals within the MFMU Network. Responsibility

    for its correct application is accepted by the enduser.

    "Development of a nomogram for prediction of

    vaginal birth after cesarean delivery," Obstetrics andGynecology, volume 109, pages 806-12, 2007.

  • 7/28/2019 Ppt Bang Ucup

    14/34

    ACOG/TOLAC CALCULATOR

    ACOG 2010

    Although there is no universally agreed ondiscriminatory point, evidence suggests thatwomen with at least

    6070% chance of VBAC Have equal or less maternal morbidity when they

    undergo TOLAC than women undergoing elective

    repeat cesarean delivery

  • 7/28/2019 Ppt Bang Ucup

    15/34

    ACOG/TOLAC CALCULATOR

    ACOG 2010

    Less than or Equal to 60%

    probability TOLAC RISK outweighthe potential benefit Failed VBAC is associated with a greater

    chance of NEONATAL AND MATERNALMORBIDITY than woman undergoing elective

    repeat cesarean delivery

  • 7/28/2019 Ppt Bang Ucup

    16/34

    The MFMU Cesarean Registry:Prospective study with > 14,500 vbac attempts

    The overall VBAC success rate in obesewomen (BMI > or = 30) was lower (68.4%)than in non obese women (79.6%) (P < .001)

    When combined with induction and lack ofprevious vaginal delivery, successful VBACoccurred in only 44.2% of cases.

    Am J Obstet Gynecol 2005 Sep;193(3 Pt 2):1016-23

  • 7/28/2019 Ppt Bang Ucup

    17/34

    Success for VBAC by History

    PREVIOUS VAGINAL DELIVERY

    Yes / 85% success No / 60% success

    PREVIOUS VBAC DELIVERY

    Yes / 85% success No / 65% success

    CERVIX 4 CM ON ADMISSION

    Yes / 85 % success No / 65% success

    SPONTANEOUS LABOR 80% success

    Am J Obstet Gynecol 2005; 193:1016

  • 7/28/2019 Ppt Bang Ucup

    18/34

    Success for VBAC by history

    Previous non recurring indication 75-85 %

    All pts with DYSTOCIA as indication 50-80%

    Latent phase C/S (4cm or less) 80%Active phase C/S ( 5 to 9 cm ) 70%

    Second stage C/S (10 & pushing) 10%

    ACOG VBAC BULLETIN # 54 2004

  • 7/28/2019 Ppt Bang Ucup

    19/34

    Increase BMI > 39 = Increased risk

    A BMI > 39 was associated with greater compositematernal morbidity and neonatal injury comparedwith elective repeat cesarean delivery

    Increasing BMI was directly associated with failedtrial of labor after previous cesarean delivery

    BMI > 39 TOLAC WAS ASSOCIATED WITH

    5 X risk of uterine rupture (2.1% vs 0.4%),

    5 X risk of neonatal injury (1.1% vs 0.2%) 2 X risk of Maternal Morbidity (7.2% versus 3.8%)

    Obstet Gynecol. 2006 Jul;108(1):125-33 MFMU

  • 7/28/2019 Ppt Bang Ucup

    20/34

    VBAC Safety and Success

    AT OR

    Beyond 40 weeks of gestation

    There is a 4% increased risk for a failed VBAC

    @ 35 % @ 41 weeks vs 31 % @ 40 weeks

    ~ 65 % successful VBAC @ 41 weeks

    The risk of overall maternal morbidity IS not

    clinically or statistically significant when

    comparing after 41 vs 40 weeks (2.7% @ 41

    weeks compared with 2.1% @ 40 0/7 weeks).

    Obstet Gynecol. 2005 Oct;106(4):700-6

  • 7/28/2019 Ppt Bang Ucup

    21/34

    40 WEEKS OR GREATER

    Although chances of success may be lower( 4%) in

    more advanced gestations, gestational age of greater

    than 40 weeks alone should not preclude TOLAC.

    Use calculator to help you decide Be cautious and include OTHER PERTINENT risk

    factors for VBAC failure or increased risk for uterine

    rupture with TOLAC in this situation such as

    Interdelivery interval, EFW ( > 3600 grams) , & Bishop

    score, Previous C/S indication,

    ACOG 2010 #115

  • 7/28/2019 Ppt Bang Ucup

    22/34

    4000 GRAMS MACROSOMIA

    Some limited evidence also suggests that the uterine

    rupture rate is increased (relative risk 2.3, P

  • 7/28/2019 Ppt Bang Ucup

    23/34

    TWINS

    Women with twin gestations had a similar chance of achieving

    VBAC as women with singleton gestations and did not incur

    any greater risk of uterine rupture or maternal or perinatal

    morbidity.

    Women with one previous cesarean delivery with a low

    transverse incision, who are otherwise appropriate candidates

    for twin vaginal delivery, may be considered candidates for

    TOLAC.

  • 7/28/2019 Ppt Bang Ucup

    24/34

    INDUCTION/AUGMENTATION

    Induced labor is less likely to result in VBAC than

    spontaneous labor, ESPECIALLY with an unfavorable cervix.

    Therefore, selecting women most likely to give birth vaginally

    while avoiding sequential use of prostaglandins and

    oxytocin appears to have the lowest risks of uterine rupture.

    The varying outcomes of available studies and small absolute

    magnitude of the risk reported in those studies support that

    oxytocinaugmentation may be used in patients undergoing

    TOLAC. 1% risk of rupture with oxytocin augmentation

    Induction utilizing mechanical dilation ( Foley Bulb distended

    to 40 ml more effective or @ least as effective as Cytotec in

    RCT) may be an option for TOLAC candidates with an

    unfavorable cervix.

  • 7/28/2019 Ppt Bang Ucup

    25/34

    COUNSELING RISK OF

    UTERINE RUPTURE

    Spontaneous labor 0.9% 1 c/s vs 1.8% for 2

    Induced TOLAC 1% - 2.4%

    Pitocin Augmented 1%

    Am J Obstet Gynecol 1999;181:882

    N Engl J Med 2004;351:2581 9

    N Engl J Med. 2001 Jul 5;345(1):3-8.

    ACOG Number 115, August 2010

  • 7/28/2019 Ppt Bang Ucup

    26/34

    IS THERE A role of UTERINE CLOSURE

    in the risk of uterine rupture

    NOT CONSISTENTLY DEMONSTARTED AS A RISK FACTOR ANDNOT INCLUDED BY ACOG AS A RISK FACTOR

    Prior single-layer closure may be associated with a

    two fold or higher risk of uterine rupture comparedwith double-layer closure. Single-layer closure should

    be avoided in women who could contemplate future

    vaginal birth after cesarean delivery.

    Bujold E Obstet Gynecol. 2010 Jul;116(1):43-50

    Bujold E Am J Obstet Gynecol. 2002;186(6):1326-30

  • 7/28/2019 Ppt Bang Ucup

    27/34

    Controversy Regarding

    Closure of the Uterus

    Only one Author (Bujold E) has demonstrated anincreased risk of uterine rupture with single vs two layer

    closure in two separate retrospective studies.

    No proven physiologic/biologic models. Inclusion ofendometrium in animal studies may be associated with

    adenomyosis and interfere with scar formation ; However

    Never been demonstrated to effect scar integrity.

    Hypoxia and/Or vascular occlusion may result in poor tissue

    healing? Locking vs Running uterine closure? Or Multiple

    hemostatic figure of 8 sutures? Never been demonstrated to

    effect scar integrity .

    Sh t I t d li I t l

  • 7/28/2019 Ppt Bang Ucup

    28/34

    Short Interdelivery IntervalTime elapsed from previous delivery date to

    current TOLAC

    Multiple studies have demonstrated that an

    Interdelivery interval < or = to 18 months may be

    associated with a two fold or higher risk of uterine

    rupture during TOLAC. Furthermore it appears that ashorter Interdelivery interval is associated with a

    greater than two fold risk of rupture.

    Obstet Gynecol. 2010 May;115(5):1003-6Obstet Gynecol. 2007 Nov;110(5):1075-82.

    Am J Obstet Gynecol. 2002 ;187(5):1199-202

    Obstet Gynecol. 2001 Feb;97(2):175-7

    Am J Obstet Gynecol 2000;183:1180

    1183

  • 7/28/2019 Ppt Bang Ucup

    29/34

    If Uterine Rupture Occurs with

    Immediately Available Team

    Risk of HIE 10-11% @ worse case estimate

    (95% confidence interval, 1.810.6%)

    Neonatal death ~ 5% @ worse case estimate(95% CI, 04.2% )

    Maternal risk of ~ 10 % for Transfusion

    5% risk for TAH ;

    30 % for TAH with Catastrophic Rupture

    ACOG Number 115, August 2010

    N Engl J Med 2001;345:3-8

  • 7/28/2019 Ppt Bang Ucup

    30/34

    Maternal Risks ERCD (%) TOLAC (%)

    One CD Two CDs

    Endometritis 1.52.1 2.9 3.1

    Operative injury 0.42.6 0.4 0.4

    Blood transfusion 11.4 0.71.7 3.2

    Hysterectomy 00.4 0.20.5 0.6

    Uterine rupture 0.40.5 0.70.9 0.91.8

    Maternal death 0.020.04 0.02 0

    ACOG Number 115, August 2010

  • 7/28/2019 Ppt Bang Ucup

    31/34

    Neonatal risk

    Short term respiratory transitional needs ~ 2 x as high

    with ERCD vs successful VBAC

    Hyperbilirubinemia ~ 2 x as high with ERCD vs

    successful VBAC

    Neonatal morbidity is higher in the setting of a failed

    TOLAC than with successful VBAC

    ( therefore < 60% success not recommended for TOLAC) Perinatal mortality is higher( includes stillbirth) with TOLAC

    vs ERCD ; however the absolute risk is ~ 1/10 of 1%ACOG Number 115, August 2010

    N Engl J Med 2004;351:25819

  • 7/28/2019 Ppt Bang Ucup

    32/34

    Neonatal Risks ERCD (%) TOLAC (%)

    IUFD 3738 weeks 0.08 0.38

    IUFD 39 weeks or greater 0.01 0.16

    HIE 0013 0.08

    Neonatal death 0.05 0.08 NS

    Perinatal death 0.01 0.13 HYPOXIA

    Neonatal admission 6.0 6.6 NS

    Respiratory morbidity 1

    5 0.1

    1.8

    Transient tachypnea 6.2 3.5

    Hyperbilirubinemia 5.8 2.2

  • 7/28/2019 Ppt Bang Ucup

    33/34

    DOCUMENTATION MANDATORY

    Documentation of counseling and the management plan

    should be included in the medical record.

    Potential benefits and risks( % ) of both TOLAC and elective

    repeat cesarean delivery should be discussed and

    documented.

    The VBAC SUCCESS CALCULATOR AND MATERNAL /NEONATAL

    RISK TABLES provided by ACOG facilitate a STANDARDIZED

    discussion that is patient specific and ENDORSED by ACOG.

    After counseling, the ultimate decision to undergo TOLAC or

    a repeat cesarean delivery should be made by the patient in

    consultation with her healthcare provider.

    Dr Montgomery Recommends

  • 7/28/2019 Ppt Bang Ucup

    34/34

    Dr Montgomery Recommends DOCUMENT COUNSELING WIH QUOTED RISK/BENEFIT % tges

    TOLAC CALCULATOR : No < 60 /60-69 Offer/ 70 or > Recommend

    Additionally consider interdelivery interval during antenatal calculation

    DO RECOMMEND For a patient who has requested TOLAC a scheduledrepeat cesarean section by 41 0/7 weeks with success calculated @ 70%For a patient who has requested TOLAC a scheduled repeat cesareansection by 40 0/7 weeks with success calculated @ < 70%

    REMEMBER EFW & modified Bishop Score as you approach 38 weeks

    Thoroughly counsel about induction or augmentation taking into accountadditional factors associated with failure and/or increased risk.

    DO RECOMMEND SCHEDULED REPEAT CESAREAN SECTION @ 39 WEEKSFOR PATIENTS WHO DECLINE TOLAC; Due to the documented increasedrisk of IUFD after 39 weeks.

    DO NOT recommend TOLAC for patients with a history of failure ofdescent (previously dilated to 10 cm) >/= to 85 % will have a failed VBACSchedule C/S @ 39 0/7 weeks for these patients.

    DO NOT recommend TOLAC For patients with a BMI of 39 or greater.Schedule C/S @ 39 0/7 weeks for these patients.